Discounted Cash Flow Calculation for NasdaqGS:HCAT using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for
is arrived at by discounting future cash flows to their present value using the 2 stage method.
We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
Note: Free cash flow to equity valuations ignore the company's cash or debt.
NasdaqGS:HCAT DCF 1st Stage: Next 10 year cash flow forecast
Amount off the current price
is available for.
Share price is
vs Future cash flow value of
Current Discount Checks
to be considered undervalued it must be available for at least 20% below the
current price. Less than 40% is even better.
Health Catalyst's share price is below the future cash flow value, and at a moderate discount (> 20%).
Health Catalyst's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Health Catalyst's earnings available for a low price, and how does
this compare to other companies in the same industry?
Health Catalyst is not considered high growth as it is expected to be loss making for the next 1-3 years.
Health Catalyst's revenue is expected to grow by 16.4% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Health Catalyst's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Daniel D. Burton, also known as Dan, has been the Chief Executive Officer of Health Catalyst, Inc. since October 2012 and has been its Director since September 2011. Mr. Burton has many years of strategy and leadership experience. He co-founded HB Ventures and has filled senior executive roles at HB Ventures portfolio companies, including the roles of Chief Executive Officer, President and Chief Marketing Officer. Prior to HB Ventures, Mr. Burton led the Corporate Strategy Group at Micron Technology. He served as President of Health Catalyst, Inc. from September 2011 to October 2012. He also spent eight years with Hewlett-Packard in Strategy and Management roles, including building and managing a technology e-business. Before joining HP, he served as an Associate Consultant with the Boston Consulting Group, where he advised healthcare systems and technology companies. Mr. Burton holds an MBA with High Distinction from Harvard University, where he was elected a George F. Baker Scholar and a BS in economics, magna cum laude, from BYU.
Insufficient data for Dan to compare compensation growth.
Dan's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the
management team in years:
The tenure for the Health Catalyst management team is about average.
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations primarily in the United States. The company operates through two segments, Technology and Professional services. Its products include cloud-based data platform, analytics software, and professional services. The company offers Data Operating System (DOS), a data platform that allows customers to integrate and organize their disparate data sources to enable analytics, including healthcare-specific terminology, data governance, and meta-data management. It also develops foundational software applications comprising Population Builder application that enables clinicians and administrators to author, manage, view, and publish pre-built and custom population ruleset definitions; Touchstone application for benchmarking solutions; and Leading Wisely application for dashboards and reporting solutions. In addition, the company provides domain-specific software applications, such as CORUS application for activity-based costing; patient safety monitor analytics; care management services; population health foundations solutions; and quality and regulatory measures solutions. Further, it offers analytics accelerators, which facilitate analytic insights across clinical, financial, and operational use-cases. Additionally, the company provides data and analytics services, including data engineering, analytic engineer, implementation, data science, analytics strategy, and data governance services; and clinical, financial, and operational services comprising quality and process improvement strategy, patient safety, cost accounting, population health and value-based care, abstraction data submission, and health catalyst university educational services. The company was founded in 2008 and is headquartered in Salt Lake City, Utah.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.